| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 870791 | IRBM | 2014 | 6 Pages |
Abstract
This paper presents an overview of the main actions and projects of the ANR TECSAN “CancerSensor” during the 2011–2014 period. The project aims to develop and validate a quantitative, non-invasive therapeutic tool to detect selected urinary modified nucleosides as biomarkers of colorectal cancer chemotherapy and to monitor in fine the efficiency of the chemotherapy. A methodology has been developed to generate a bulk acoustic wave molecularly imprinted polymer sensor (SAW-MIP) for the detection of various nucleosides and nucleotides of interest. A rapid and sensitive mass spectrometry method has been also developed.
Related Topics
Physical Sciences and Engineering
Engineering
Biomedical Engineering
Authors
L.A. Agrofoglio, A. Krstulja, C. De Schutter, P. Favetta, R. Delépée, V. Roy, C. Dejous, H. Hallil, J.-L. Lachaud, N. Lebal, N. Omar Aouled, V. Raimbault, D. Rebière, S. Dulong, F. Levi, C. Junot, F. Théodoro, A. Pruvost, R. Vidal,